Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN · NASDAQ Global Market
+$0.51 today
Vol 0.90M · Avg 0.64M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+38.73%
Period High
$57.00
Period Low
$31.16
Latest
$44.38
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Lantheus Holdings, Inc.
NASDAQ:LNTH
$6.75B
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.17B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.36B
Amneal Pharmaceuticals, Inc.
NASDAQ:AMRX
$5.03B
Indivior Pharmaceuticals Inc
NASDAQ:INDV
$4.78B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.18B
GRAIL, Inc.
NASDAQ:GRAL
$2.63B
HUTCHMED (China) Limited
NASDAQ:HCM
$1.79B
Bausch Health Companies Inc.
NYSE:BHC
$1.76B
Perrigo Company plc
NYSE:PRGO
$1.37B
What is the latest SUPN filing?
The latest filing shown is 8-K dated May 20, 2026.
How many recent filings does SUPN have?
Intrinsic Alpha currently shows 20 recent filings for SUPN.
Explore More
Continue the stock analysis
Jump to another research area for this company.